California State Teachers Retirement System (CalSTRS)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,885
| Closed | -$7.06K | – | 3030 |
|
|
2026
Q1 | $7.06K | Sell |
5,885
-801
| -12% | -$975 | ﹤0.01% | 2795 |
|
|
2025
Q4 | $6.57K | Sell |
6,686
-573
| -8% | -$688 | ﹤0.01% | 2907 |
|
|
2025
Q3 | $9.15K | Buy |
7,259
+5
| +0.1% | +$5 | ﹤0.01% | 2859 |
|
|
2025
Q2 | $8.12K | Hold |
7,254
| – | – | ﹤0.01% | 2806 |
|
|
2025
Q1 | $5.73K | Hold |
7,254
| – | – | ﹤0.01% | 2896 |
|
|
2024
Q4 | $12K | Sell |
7,254
-74,524
| -91% | -$188K | ﹤0.01% | 2794 |
|
|
2024
Q3 | $286K | Sell |
81,778
-7,875
| -9% | -$30.6K | ﹤0.01% | 2313 |
|
|
2024
Q2 | $294K | Buy |
89,653
+81,133
| +952% | +$355K | ﹤0.01% | 2306 |
|
|
2024
Q1 | $62.5K | Sell |
8,520
-5,430
| -39% | -$33.6K | ﹤0.01% | 2484 |
|
|
2023
Q4 | $52.2K | Sell |
13,950
-74,271
| -84% | -$175K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $187K | Sell |
88,221
-9,047
| -9% | -$30K | ﹤0.01% | 2516 |
|
|
2023
Q2 | $463K | Sell |
97,268
-1,927
| -2% | -$10.6K | ﹤0.01% | 2337 |
|
|
2023
Q1 | $565K | Sell |
99,195
-1,394
| -1% | -$8.41K | ﹤0.01% | 2245 |
|
|
2022
Q4 | $1.01M | Buy |
100,589
+1,248
| +1% | +$23.4K | ﹤0.01% | 1886 |
|
|
2022
Q3 | $2.23M | Sell |
99,341
-1,867
| -2% | -$53.9K | ﹤0.01% | 1368 |
|
|
2022
Q2 | $2.51M | Buy |
101,208
+1,419
| +1% | +$39.2K | ﹤0.01% | 1344 |
|
|
2022
Q1 | $3.87M | Sell |
99,789
-8,800
| -8% | -$341K | 0.01% | 1204 |
|
|
2021
Q4 | $6.35M | Buy |
108,589
+3,094
| +3% | +$175K | 0.01% | 1006 |
|
|
2021
Q3 | $6.25M | Sell |
105,495
-5,008
| -5% | -$393K | 0.01% | 1026 |
|
|
2021
Q2 | $9.59M | Sell |
110,503
-4,360
| -4% | -$351K | 0.01% | 849 |
|
|
2021
Q1 | $9.47M | Buy |
114,863
+6,520
| +6% | +$625K | 0.01% | 825 |
|
|
2020
Q4 | $9.85M | Sell |
108,343
-64
| -0.1% | -$3.97K | 0.01% | 770 |
|
|
2020
Q3 | $4.33M | Buy |
108,407
+13,967
| +15% | +$488K | 0.01% | 1039 |
|
|
2020
Q2 | $3.24M | Buy |
94,440
+2,236
| +2% | +$66.6K | 0.01% | 1187 |
|
|
2020
Q1 | $2.05M | Sell |
92,204
-457
| -0.5% | -$11.6K | ﹤0.01% | 1282 |
|
|
2019
Q4 | $1.81M | Buy |
92,661
+11,143
| +14% | +$177K | ﹤0.01% | 1625 |
|
|
2019
Q3 | $1.27M | Buy |
81,518
+974
| +1% | +$18.7K | ﹤0.01% | 1784 |
|
|
2019
Q2 | $1.64M | Sell |
80,544
-13,005
| -14% | -$234K | ﹤0.01% | 1672 |
|
|
2019
Q1 | $1.64M | Sell |
93,549
-1,386
| -1% | -$21.9K | ﹤0.01% | 1644 |
|
|
2018
Q4 | $1.22M | Buy |
94,935
+18,104
| +24% | +$252K | ﹤0.01% | 1780 |
|
|
2018
Q3 | $1.25M | Buy |
76,831
+780
| +1% | +$9.22K | ﹤0.01% | 1920 |
|
|
2018
Q2 | $862K | Buy |
76,051
+2,519
| +3% | +$27.8K | ﹤0.01% | 2148 |
|
|
2018
Q1 | $718K | Buy |
73,532
+13,032
| +22% | +$125K | ﹤0.01% | 2159 |
|
|
2017
Q4 | $370K | Sell |
60,500
-2,200
| -4% | -$9.82K | ﹤0.01% | 2548 |
|
|
2017
Q3 | $248K | Sell |
62,700
-4,800
| -7% | -$16.3K | ﹤0.01% | 2802 |
|
|
2017
Q2 | $219K | Buy |
+67,500
| New | +$259K | ﹤0.01% | 2902 |
|
Other funds holding FATE
RG
JJ
California State Teachers Retirement System (CalSTRS)'s FATE Position: Q2 2026 in Review
California State Teachers Retirement System (CalSTRS) sold out of Fate Therapeutics (FATE) in Q2 2026, closing a stake of 5,885 shares — an estimated $7.06K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in FATE in Q2 2017 and held it in 36 quarters. The position peaked at $9.85M in Q4 2020. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.
- California State Teachers Retirement System (CalSTRS) reported no remaining Fate Therapeutics position as of Q2 2026 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 5,885 Fate Therapeutics shares in Q2 2026, an estimated $7.06K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Fate Therapeutics in Q2 2017 and held it in 36 quarters.
- California State Teachers Retirement System (CalSTRS)'s Fate Therapeutics position peaked at $9.85M in Q4 2020.
- 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.